Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
14.24
-0.97 (-6.38%)
At close: Apr 1, 2025, 4:00 PM
14.08
-0.16 (-1.14%)
After-hours: Apr 1, 2025, 4:26 PM EDT

Tourmaline Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-73.21-42.12-19.7-0.9
Depreciation & Amortization
0.040.030.01-
Asset Writedown & Restructuring Costs
-8.8212.13-
Loss (Gain) From Sale of Investments
-7.68-0.54--
Stock-Based Compensation
6.595.770.2-
Other Operating Activities
0.150.120.02-
Change in Accounts Payable
2.44-0.040.190.78
Change in Other Net Operating Assets
-5.59-0.120.710.13
Operating Cash Flow
-77.26-28.08-6.46-
Capital Expenditures
-0.01-0.06-0.07-
Sale (Purchase) of Intangibles
---5-
Investment in Securities
-194.33.9--
Investing Cash Flow
-194.313.84-5.07-
Short-Term Debt Issued
--0.25-
Total Debt Issued
--0.250.6
Short-Term Debt Repaid
---0.4-
Total Debt Repaid
---0.4-
Net Debt Issued (Repaid)
---0.150.6
Issuance of Common Stock
161.350.14--
Repurchase of Common Stock
-0---
Other Financing Activities
-64.75--
Financing Cash Flow
161.35156.7219.850.6
Net Cash Flow
-110.22132.488.320.6
Free Cash Flow
-77.27-28.14-6.53-
Free Cash Flow Per Share
-3.05-5.93-7.44-
Levered Free Cash Flow
-50.17-24.92-16.26-
Unlevered Free Cash Flow
-50.17-24.92-16.26-
Change in Net Working Capital
0.722.29-0.92-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q